Worldwide, in Africa and Ethiopia prevalence of Benign Prostatic Hyperplasia among patients with lower urinary tract symptoms was 26.2%, 44.2%, and 33.4% respectively. However, there is limited evidence regarding Benign Prostatic Hyperplasia in southern Ethiopia and it was not well explored. Therefore, this study aimed to assess the magnitude and associated factors of Benign Prostatic Hyperplasia among adult male patients visiting Wolaita Sodo University Comprehensive Specialized Hospital, southern Ethiopia 2022. A hospital-based cross-sectional study was conducted from July to September 2022. A systematic random sample technique was employed to select 376 participants. Data were gathered using a structured questionnaire and entered, cleaned, coded, and analyzed using SPSS Version 25.0. To describe the study respondents, descriptive statistics were used. Bivariate and multivariate analyses were conducted and an adjusted odd ratio with 95% Confidence Interval (CI) was utilized to quantify the degree of association, and statistical significance was declared at p-value < 0.05. A total of 376 male patients admitted to the surgical department of the Urology ward were included in this study and the magnitude of Prostatic Hyperplasia was 21.3%; 95% CI: 17.3, 25.8. The vegetable consumption, fruit consumption, physical activity, sleeping time and sexual dysfunction [(AOR = 7.57, 95% CI: (2.78, 20.60)], [(AOR = 21.06,95% CI: (7.06,27.53)], [(AOR = 0.57,95% CI: (0.19, 0.67)], [(AOR = 3.23, 95% CI: (1.18,8.79)] and [(AOR = 17.05, 95% CI: (4.82,60.28)] were factors associated with Benign Prostatic Hyperplasia respectively. The benign prostatic hyperplasia is a prevalent disease among men in this study. Sexual dysfunction, consumption of vegetables, consumption of fruits, practice of physical activity and sleeping time were factors associated with BPH. Hence, screening programs for higher-risk people to ensure the early presentation of benign prostatic hyperplasia and practicing eating balanced diets are vital areas to reduce the prevalence.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-024-83483-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11685705PMC

Publication Analysis

Top Keywords

benign prostatic
16
prostatic hyperplasia
16
southern ethiopia
12
hyperplasia adult
8
adult male
8
male patients
8
patients visiting
8
visiting wolaita
8
wolaita sodo
8
sodo university
8

Similar Publications

To investigate the potential of an MRI-based radiomic model in distinguishing malignant prostate cancer (PCa) nodules from benign prostatic hyperplasia (BPH)-, as well as determining the incremental value of radiomic features to clinical variables, such as prostate-specific antigen (PSA) level and Prostate Imaging Reporting and Data System (PI-RADS) score. A restrospective analysis was performed on a total of 251 patients (training cohort, n = 119; internal validation cohort, n = 52; and external validation cohort, n = 80) with prostatic nodules who underwent biparametric MRI at two hospitals between January 2018 and December 2020. A total of 1130 radiomic features were extracted from each MRI sequence, including shape-based features, gray-level histogram-based features, texture features, and wavelet features.

View Article and Find Full Text PDF

Introduction: Prostate cancer is incidentally diagnosed in 6%-11% of benign prostatic hyperplasia surgeries.

Case Presentation: A 79-year-old man was diagnosed with benign prostatic hyperplasia. The prostate volume was 54.

View Article and Find Full Text PDF

Prostate fibrosis contributes to lower urinary tract dysfunction (LUTD). To develop targeted treatments for prostate fibrosis, it is necessary to identify cell types and molecular pathways required for collagen production. We used a genetic approach to label and track potential collagen-producing cell lineages in mouse prostate through a round of Escherichia coli (E.

View Article and Find Full Text PDF

Background: The Nectin-4 directed antibody drug conjugate enfortumab vedotin (EV) has emerged as frontline systemic therapy in combination with immune checkpoint blockade for urothelial carcinoma (UC), capitalizing on the ubiquitous expression of this protein in UC. There is limited data available regarding expression of Nectin-4 by immunohistochemistry in prostate cancer, but this is of interest as a substantial number of UC patients likely to receive EV have concomitant prostate cancer.

Methods: Nectin-4 protein expression was evaluated by immunohistochemistry in tissue microarrays encompassing a cohort of 302 prostatic adenocarcinomas spanning Grade Groups 1-5.

View Article and Find Full Text PDF

To investigate the relationship between the Chinese Visceral Adiposity Index (CVAI) and the risk of developing Benign Prostatic Hyperplasia (BPH). Using data from the China Health and Retirement Longitudinal Study (CHARLS), we included 3,295 men aged 45 years and older. Multivariate logistic regression and restricted cubic spline models were employed to analyze the association between CVAI and the risk of BPH.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!